Welcome to the international HTA database

Showing [23371 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Agency for Healthcare Research and Quality (AHRQ)	Assessment and management of chronic cough
2013	Agency for Healthcare Research and Quality (AHRQ)	The ankle brachial index for peripheral artery disease screening and cardiovascular disease prediction in asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Overview of the drugs used by children and adolescents diagnosed with autism spectrum disorder who are covered by the Public Prescription Drug Insurance Plan]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Beta human chorionic gonadotropin test for detection of early pregnancy: clinical effectiveness, cost-effectiveness, and guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Falls in patients living in health care facilities (short- and long-term care)]
2013	Institute of Health Economics (IHE)	Islet transplantation for the treatment of type 1 diabetes [update]
2013	Malaysian Health Technology Assessment (MaHTAS)	Collagen for anti aging treatment, enhance cell regeneration and boosting the immune system
2013	National Institute for Health and Care Excellence (NICE)	Insertion of endobronchial valves for persistent air leaks. NICE interventional procedures guidance 448
2013	NIHR Health Technology Assessment programme	Randomised Assessment of Treatment using Panel Assay of Cardiac markers - Contemporary Biomarker Evaluation (RATPAC CBE)
2013	Agency for Healthcare Research and Quality (AHRQ)	Outpatient case management for adults with medical illness and complex care needs
2013	Scottish Health Technologies Group (SHTG)	What approaches have been taken and efforts made to ensure public involvement in decision making relating to potential disinvestment in healthcare interventions and technologies?
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for hypertension in children and adolescents to prevent cardiovascular disease: systematic review for the U.S. Preventive Services Task Force.
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of intrathecal pumps for the treatment of chronic non-cancer pain]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interventions used to determine the appropriate patient populations for cataract surgery: a review of the clinical evidence and guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Self-monitoring of blood glucose in adult patients with Type 2 Diabetes not using insulin]
2013	National Institute for Health and Care Excellence (NICE)	Percutaneous electrical nerve stimulation for refractory neuropathic pain. NICE interventional procedures guidance 450
2013	NIHR Health Technology Assessment programme	The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial
2013	Agency for Healthcare Research and Quality (AHRQ)	Child and adolescent exposure to trauma: comparative effectiveness of interventions addressing trauma other than maltreatment or family violence
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry: Maple Syrup Urine Disease, Homocystinuria, Glutaric Aciduria Type I, Isovaleric Acidaemia, Long-chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency]
2013	Agency for Healthcare Research and Quality (AHRQ)	Behavioral interventions and counseling to prevent child abuse and neglect: systematic review to update the U.S. Preventive Services Task Force Recommendation.
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Sublingual immunotherapy for respiratory allergies]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antimicrobial drapes for the reduction of surgical site infection: clinical effectiveness
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Efficiency of short-term social and psychological therapies: Systematic review]
2013	National Institute for Health and Care Excellence (NICE)	Peripheral nerve-field stimulation for chronic low back pain. NICE interventional procedures guidance 451
2013	Agency for Healthcare Research and Quality (AHRQ)	Intravascular diagnostic procedures and imaging techniques versus angiography alone in coronary artery stenting: comparative effectiveness review
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Development of quality indicators for laser treatment for benign prostatic hyperplasia. Expert consensus]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Compression bandage measurement devices for the use in adult patients with chronic venous insufficiency: clinical effectiveness
2013	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Implantable devices for the closure of patent foramen ovale (PFO) in adults. Rapid HTA report
2013	Malaysian Health Technology Assessment (MaHTAS)	Negative pressure wound therapy (Renasys Go Console Package)
2013	National Institute for Health and Care Excellence (NICE)	Irreversible electroporation for treating primary lung cancer and metastases in the lung. NICE interventional procedures guidance 441
2013	The Netherlands Organisation for Health Research and Development (ZonMw)	[Laparoscopic ileocolic resection versus infliximab treatment of recurrent distal ileitis in Crohn's disease: a randomized multicenter trial]
2013	NIHR Health Technology Assessment programme	Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation
2013	Agency for Healthcare Research and Quality (AHRQ)	Insulin delivery and glucose monitoring methods: future research needs
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Eribulin mesilate (Halaven) for advanced non-small cell lung cancer – third line
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Current strategies for optimizing the relevance of laboratory test prescription: a review of Canadian and international experiences]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Techniques for renal biopsy: guidelines
2013	Norwegian Knowledge Centre for the Health Services (NOKC)	Health technology assessment of the different dialysis modalities in Norway
2013	Health Council of the Netherlands Gezondheidsraad (GR)	A closer look at Lyme disease
2013	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Evaluation of efficacy and safety of PET-CT (update)]
2013	Malaysian Health Technology Assessment (MaHTAS)	Photodynamic therapy for cancer treatment – an update
2013	National Institute for Health and Care Excellence (NICE)	Irreversible electroporation for treating renal cancer. NICE interventional procedures guidance 443
2013	NIHR Health Technology Assessment programme	Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review
2013	NIHR Health Technology Assessment programme	Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
2013	Agency for Healthcare Research and Quality (AHRQ)	Efficacy and safety of screening for postpartum depression
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Olaparib for relapsed platinum-sensitive ovarian cancer
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Patient-based funding: a literature review of experiences in other countries]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Peripherally Inserted Central Catheters (PICCs) for adult and pediatric patients: a review of clinical evidence
2013	Health Council of the Netherlands Gezondheidsraad (GR)	The maximum number of children per sperm donor
2013	Malaysian Health Technology Assessment (MaHTAS)	Placenta for cosmetic purpose and cell regeneration
2013	National Institute for Health and Care Excellence (NICE)	Irreversible electroporation for treating liver metastases. NICE interventional procedures guidance 445
2013	Agency for Healthcare Research and Quality (AHRQ)	Technology assessment on genetic testing or molecular pathology testing of cancers with unknown primary site to determine origin
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Plitidepsin (Aplidin) in combination with dexamethasone for multiple myeloma – third line
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Notice regarding field trauma triage criteria]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin D supplementation in long-term care residents: clinical evidence and guidelines
2013	National Institute for Health and Care Excellence (NICE)	Ultrasound-guided foam sclerotherapy for varicose veins. NICE interventional procedures guidance 440
2013	National Institute for Health and Care Excellence (NICE)	Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel. NICE diagnostics guidance 11
2013	Agency for Healthcare Research and Quality (AHRQ)	Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) testing of uterine cervical cells to predict precancer and cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Darapladib for cardiovascular risk reduction in patients with coronary heart disease – add on therapy
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Effectiveness of short term social and psychological interventions: a systematic review]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	High-sensitivity cardiac troponin for the rapid diagnosis of acute coronary syndrome in the emergency department: a clinical and cost-effectiveness evaluation
2013	Malaysian Health Technology Assessment (MaHTAS)	Namyang Ketonia – ketogenic diet treatment for epilepsy
2013	National Institute for Health and Care Excellence (NICE)	Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction. NICE interventional procedures guidance 436
2013	National Institute for Health and Care Excellence (NICE)	EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer. NICE diagnostics guidance 9
2013	NIHR Health Technology Assessment programme	Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Colorectal-cancer-screening update; status in Austria and European countries; and quality assurance of screening-colonoscopy]
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ezetimibe and simvastatin (Inegy) for reduction of cardiovascular risk in coronary heart disease
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	lisdexamfetamine dimesylate (Elvanse®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Recommendations for the use of troponin assays for rapid diagnosis of acute coronary syndrome in the emergency department
2013	National Institute for Health and Care Excellence (NICE)	Autologous blood injection for plantar fasciitis. NICE interventional procedures guidance 437
2013	National Institute for Health and Care Excellence (NICE)	Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer. NICE diagnostics guidance 8
2013	NIHR Health Technology Assessment programme	A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE)
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Spectropath Image-Guided Surgery System with Spectropen™ for cancer surgery
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Pazopanib (Votrient®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cataract surgery performed in settings other than hospital operating rooms: clinical effectiveness, cost-effectiveness, and guidelines
2013	Technology Assessment at SickKids (TASK)	Thiopurine dosing using thiopurine methyltransferase status: a systematic review of clinical guidance
2013	National Institute for Health and Care Excellence (NICE)	Autologous blood injection for tendinopathy. NICE interventional procedures guidance 438
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Neochord DS1000™ system for mitral valve regurgitation
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	5-aminolaevulinic acid (Ameluz®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fecal bacteriotherapy for patients with recurrent C. difficile: clinical effectiveness and guidelines
2013	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Economic evaluation of drug eluting stents in the treatment of ischemic heart disease (update)]
2013	National Institute for Health and Care Excellence (NICE)	Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy. NICE interventional procedures guidance 439
2013	NIHR Health Technology Assessment programme	Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study
2013	NIHR Health Technology Assessment programme	Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Eliglustat for gaucher disease
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Elvitegravir/cobicistat/emtricitabine/tenofovir (Stribild®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Techniques for the management of temporary epicardial pacemaker leads: clinical evidence, safety, and guidelines
2013	Norwegian Knowledge Centre for the Health Services (NOKC)	[Relationships between intake of alcoholic beverages and the risk of cardiovascular disease]
2013	Malaysian Health Technology Assessment (MaHTAS)	Epidermal Growth Factor Receptor (EGFR) mutation test for patients with Non-Small Cell Lung Cancer (NSCLC)
2013	NIHR Health Technology Assessment programme	Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive candida infection: the Fungal Infection Risk Evaluation (FIRE) study
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Aflibercept (Eylea) for visual impairment due to diabetic macular oedema – first line
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Raltegravir (Isentress®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effect of single room vs contact isolation containment rooms]
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Marketing authorisations under exceptional circumstances for oncology drugs: an analysis of approval and reimbursement decisions of four drugs
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Inflectra (infliximab biosimilar) for ankylosing spondylitis
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tegafur/gimeracil/oteracil (Teysuno®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tricyclic antidepressants, clonidine, venlafaxine, and modafinil for the treatment of attention-deficit/hyperactivity disorder in adults: a review of the clinical evidence
2013	Agency for Healthcare Research and Quality (AHRQ)	Communication and dissemination strategies to facilitate the use of health-related evidence
2013	Norwegian Knowledge Centre for the Health Services (NOKC)	[Discharging patients with chronic disease: effect of various forms of cooperation between hospital and the community health service]